InMode Lowers Revenue Forecast Amid Market Challenges, GuruFocus Sees Significant Upside

InMode (INMD) lowers Q2 2025 revenue forecast to $95.4-95.5mln, missing consensus estimate of $98.45mln. The company adjusts its full-year 2025 revenue projection to $365-375mln, down from $395-405mln. Wall Street analysts hold a mixed outlook with a "Hold" recommendation and varied price targets. GuruFocus estimates a significant upside of 55.41% based on GF Value assessment.

InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, has announced revised revenue forecasts for the second quarter of 2025. The company expects revenue to range between $95.4 million and $95.5 million, a significant drop from the previously projected $98.45 million, according to consensus estimates [2].

The adjustment in revenue projections reflects the ongoing economic uncertainty and market weakness, which have led to a downward revision in InMode's full-year 2025 revenue guidance. The company now anticipates full-year revenue to be in the range of $365 million to $375 million, down from the prior guidance of $395 million to $405 million [1].

InMode will host a conference call on Wednesday, July 30, 2025, at 8:30 a.m. Eastern Time, to discuss the second quarter 2025 financial results. The call will feature Moshe Mizrahy, Chief Executive Officer, Yair Malca, Chief Financial Officer, and Dr. Michael Kreindel, Chief Technology Officer [1].

The stock market's response to InMode's revised guidance has been mixed, with analysts providing a "Hold" recommendation and varied price targets. GuruFocus estimates a significant upside of 55.41% based on its GF Value assessment [3].

References:
[1] https://finance.yahoo.com/news/inmode-report-second-quarter-2025-110000156.html
[2] https://www.marketscreener.com/quote/stock/INMODE-LTD-63383136/news/Inmode-Ltd-Provides-Revenue-Guidance-for-the-Second-Quarter-of-2025-50479453/
[3] https://simplywall.st/stocks/us/healthcare/nasdaq-inmd/inmode/future